Skip to main content

Table 1 Patient characteristics in the study

From: A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma

Variable

Total (n = 4971)

Training Cohort (n = 3479)

Validation Cohort (n = 1492)

P

Age, median (25th–75th percentile

63(54–72)

63(54–72)

63(54–72)

0.821

Sex n (%)

   

0.475

 Male

2597 (52.2)

1806 (51.9)

791 (53.0)

 

 Female

2374 (47.7)

1673 (48.1)

701 (47.0)

 

Race n (%)

   

0.832

 White

3929 (79.0)

2751 (79.2)

1173 (78.6)

 

 Black

824 (16.6)

574 (16.5)

250 (16.7)

 

 Other

218 (4.4)

149 (4.3)

69 (4.6)

 

Marital status n (%)

   

0.895

 Married

3135 (63.1)

2192 (63.0)

943 (63.2)

 

 Unmarried

1836 (36.9)

1287 (37.0)

549 (36.8)

 

Grade n (%)

   

0.143

 I

2962 (59.6)

2080 (59.8)

882 (59.1)

 

 II

1412 (28.4)

1000 (28.7)

412 (27.6)

 

 III

565 (11.4)

374 (10.7)

191 (12.8)

 

 IV

32 (0.6)

25 (0.7)

7 (0.5)

 

AJCC TNM stage n (%)

   

0.062

 I

729 (14.7)

541 (15.5)

188 (12.6)

 

 II

1024 (20.6)

707 (20.0)

317 (21.2)

 

 III

2108 (42.4)

1459 (41.9)

649 (43.5)

 

 IV

1110 (22.3)

772 (22.2)

338 (22.6)

 

Insurance Status

   

0.279

 Insured

4320 (86.9)

3038 (87.3)

1282 (85.9)

 

 Medicaid

497 (10.0)

341 (9.8)

156 (10.4)

 

 Uninsured

154 (3.1)

100 (2.9)

54 (3.6)

 

Surgery

   

0.199

 Yes

4525 (91.0)

3155 (90.7)

1370 (91.8)

 

 No

446 (9.0)

324 (9.3)

122 (8.2)

 

Radiation

   

0.628

 Yes

111 (2.2)

80 (2.3)

31 (2.1)

 

 No

4860 (97.7)

3399 (97.7)

1461 (97.9)

 

Chemotherapy

   

0.432

 Yes

897 (18.0)

618 (17.8)

279 (18.7)

 

 No

4074 (81.9)

2861 (82.2)

1213 (81.2)

Â